Managed Care Programs

• 

  Subject Areas on Research

  • A Primer for Managed Care Residents: How to Conduct Research Using Live Medical and Pharmacy Claims Data. 
  • A comparison of self-reported utilization of ophthalmic care for diabetes in managed care versus fee-for-service. 
  • A response to representatives from the social HMOs regarding program evaluation. 
  • A survey of beliefs about managed care. 
  • Advanced practice psychiatric nursing: a national profile. 
  • An organizational and economic framework for restructuring psychiatric nurse labor use. 
  • Are we there yet? Seizing the moment to integrate medicine and public health. 
  • Are we there yet? Seizing the moment to integrate medicine and public health. 
  • Association Between Gastrointestinal Events and Health Care Resource Utilization Among Patients with Osteoporosis: Analysis of a U.S. Managed Care Population. 
  • Association between atopy and herpetic eye disease: results from the pacific ocular inflammation study. 
  • Association between statin use and uveitis: results from the Pacific Ocular Inflammation study. 
  • Behind closed doors: management of patient expectations in primary care practices. 
  • Better Evidence to Guide Payment Reforms: Recognizing the Importance of Perspective. 
  • Cancer, comorbidities, and health-related quality of life of older adults. 
  • Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. 
  • Characteristics of eye care practices with managed care contracts. 
  • Chronic hepatitis C: an age wave of disease burden. 
  • Cigarette smoking and health-related quality of life in Medicare beneficiaries. 
  • Commercialism in nonprofit hospitals. 
  • Community impact of anticoagulation services: rationale and design of the Managing Anticoagulation Services Trial (MAST). 
  • Cost-effectiveness of improving primary care treatment of late-life depression. 
  • Cultural and organizational implications of academic managed-care networks. 
  • Current management of glaucoma and the need for complete therapy. 
  • Datapoints: Effects of changing from five to ten preauthorized outpatient sessions. 
  • Disease management in healthcare organizations: results of in-depth interviews with disease management decision makers. 
  • Do we understand the effects of 'managed care' in ophthalmology? A review and analysis. 
  • Does Medicaid pay more to a program of all-inclusive care for the elderly (PACE) than for fee-for-service long-term care? 
  • Duke Case-Mix System (DUMIX) for ambulatory health care. 
  • Dyspnea and pain frequently co-occur among Medicare managed care recipients. 
  • Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs. 
  • Economic winners and losers after introduction of an effective new therapy depend on the type of payment system. 
  • Economics of low-molecular weight heparins. 
  • Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy. 
  • Effects of Tennessee Medicaid managed care on obstetrical care and birth outcomes. 
  • Effects of insurance status on children's access to specialty care: a systematic review of the literature. 
  • Effects of state managed care patient protection laws on physician satisfaction. 
  • Employee demand for health insurance and employer health plan choices. 
  • Financing pediatric psychology: on "Buddy, can you spare a dime?". 
  • Foster care and Medicaid managed care. 
  • From physician to consumer: the effectiveness of strategies to manage health care utilization. 
  • Geographic Variation in the Rate and Timing of Cataract Surgery Among US Communities. 
  • Geriatric rehabilitation: state of the art. 
  • Health plan performance measurement: does it affect quality of care for Medicare managed care enrollees? 
  • Health reform in the private sector: initiatives of the American Managed Behavioral Healthcare Association. 
  • Healthcare cost differences with participation in a community-based group physical activity benefit for medicare managed care health plan members. 
  • Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis. 
  • How Medicaid and Managed Care Can Support Evidence-Based Treatment in North Carolina That is Informed by Adverse Childhood Experiences. 
  • How mental health providers see managed care. 
  • Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes. 
  • Impact of generalized social anxiety disorder in managed care. 
  • Impact of managed care on the treatment, costs, and outcomes of fee-for-service Medicare patients with acute myocardial infarction. 
  • Impact of medicaid managed care on utilization of obstetric care: evidence from TennCare's early years. 
  • Impacts of managed care patient protection laws on health services utilization and patient satisfaction with care. 
  • Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial. 
  • Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. 
  • Ineffective use of condoms among young women in managed care. 
  • Influence of Managed Care on the Variation in Rate and Timing of Cataract Surgery-Reply. 
  • Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation. 
  • Initial level of care and clinical status in a managed mental health program. 
  • Lying for patients: physician deception of third-party payers. 
  • Lying to insurance companies: the desire to deceive among physicians and the public. 
  • Making it happen: managed care considerations in vanquishing hepatitis C. 
  • Making quality important. 
  • Managed behavioral health care: a Medicaid carve-out for youth. 
  • Managed care does not lower costs but may result in poorer outcomes for patients with gestational diabetes. 
  • Managed care in California. Daunting new realities for dermatology and academic medicine. 
  • Managed care organizations should not disclose their physicians' financial incentives. 
  • Managed care: rationing without justice, but not unjustly. 
  • Managed outcomes: a strategy to improve the nation's health. 
  • Managed-Medicare health club benefit and reduced health care costs among older adults. 
  • Medicaid managed care partnerships to improve perinatal outcomes. 
  • Medicaid, managed care, and the care of patients hospitalized for acute myocardial infarction. 
  • Medicare managed care enrollment by disability-eligible and age-eligible veterans. 
  • Modeling the Budgetary Impact of Payer Utilization Management Strategies: An Adapted Framework Based on Lessons Learned. 
  • Need for eye care among older adults with diabetes mellitus in fee-for-service and managed Medicare. 
  • Nonabandonment: medical ethics. 
  • Obesity and managed care: a role for activism and advocacy? 
  • Obstetrician-gynecologist as primary care provider. 
  • Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure. 
  • Outpatient diagnostic errors: unrecognized hyperglycemia. 
  • Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. 
  • Patient and provider interventions for managing osteoarthritis in primary care: protocols for two randomized controlled trials. 
  • Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up. 
  • Patterns of care for open-angle glaucoma in managed care. 
  • Physician participation and nonparticipation in Medicaid managed care: the TennCare experience. 
  • Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. 
  • Population-based assessment of adverse events associated with long-term glucocorticoid use. 
  • Population-based clinical decision support: a clinical and economic evaluation. 
  • Population-based hepatitis C surveillance and treatment in a national managed care organization. 
  • Rate and predictors of glycemic testing of nondiabetic patients in a managed care population. 
  • Rates of Vitrectomy among Enrollees in a United States Managed Care Network, 2001-2012. 
  • Recommendations of the Little Rock Working Group on Mental and Substance Abuse Disorders in Health-Care Reform. 
  • Reducing bias in cancer research: application of propensity score matching. 
  • Relationship of clinical case management to hospitalization and service delivery for seriously mentally ill clients. 
  • Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States. 
  • Should managed care organizations pay for nicotine replacement therapy? 
  • Spiritual beliefs and barriers among managed care practitioners. 
  • Statin safety: an assessment using an administrative claims database. 
  • Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study. 
  • TennCare patients in chronic pain: is Medicaid reform really different? 
  • The CHAMPUS Tidewater Demonstration Project. 
  • The benefit of implementing a heart failure disease management program. 
  • The economic burden of anxiety disorders in the 1990s. 
  • The economic burden of major adult visual disorders in the United States. 
  • The effects of a managed care educational program on faculty and trainee knowledge, attitudes, and behavioral intentions. 
  • The evaluation of the Fort Bragg Demonstration Project: an alternative interpretation of the findings. 
  • The family and disease management in Hispanic and European-American patients with type 2 diabetes. 
  • The incremental value of medical nutrition therapy in weight management. 
  • Time: the forgotten outcome. 
  • Trust in managed care organizations. 
  • Use of board certification and recertification of pediatricians in health plan credentialing policies. 
  • Use of econometric models to estimate expenditure shares. 
  • Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. 
  • Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools. 
  • Validating a Budget Impact Model Using Payer Insight and Claims Data: A Framework and Case Study. 
  • What Contributes Most to High Health Care Costs? Health Care Spending in High Resource Patients. 
  • What drives outcomes for emotional and behavioral disorders in children and adolescents? 
• 

  Keywords of People

  • Allen, Kelli Dominick, Adjunct Professor in the Department of Medicine, Medicine, General Internal Medicine
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Yancy Jr., William Samuel, Associate Professor of Medicine, Medicine, General Internal Medicine